Explainable AI for Predicting Hospital Admissions in Heart Failure: ExplAIn-HF
ExplAIn-HF
1 other identifier
observational
95
0 countries
N/A
Brief Summary
The goal of this observational study is to develop and validate an XAI based model that predicts HF events and identifies modifiable con-tributing factors, and to evaluate the added value of integrating high frequency smartwatch data compared to usual care in patients with heart failure. The main objectives of the study are:
- 1.To develop and validate an XAI based model that predicts HF events and identifies modifiable contributing factors, and to evaluate the added value of integrating high frequency smartwatch data compared to usual care. In the Netherlands usual care includes remote monitoring of heartrate, blood pressure, weight and symptoms.
- 2.To include insights of the smartwatch into activity patterns, impact on quality of life (KCCQ-12), and patient satisfaction with net promoter score (NPS).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2026
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 1, 2026
CompletedStudy Start
First participant enrolled
July 1, 2026
CompletedFirst Posted
Study publicly available on registry
July 8, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2027
July 8, 2026
June 1, 2026
1.4 years
July 1, 2026
July 1, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Heart failure (HF) event
HF event is defined as: * Increase in diuretic treatment * Increase in NYHA class * Hospitalization caused by HF * Death caused by HF
From enrollment to the end of follow-up at 6 months
Secondary Outcomes (3)
Activity patterns
From enrollment to the end of follow-up at 6 months
Quality of life (QoL)
Measured at baseline and at the end of follow-up at 6 months
Net promotor score (NPS)
At the end of follow-up at 6 months
Study Arms (1)
Heart failure patients
Eligibility Criteria
Patients will be selected after HF hospitalization at three hospitals: Medisch Spectrum Twente (MST), Hospital Group Twente (ZGT), and Deventer hospital.
You may qualify if:
- Adult HF patients
- NYHA class II, or NYHA III
- Recent hospitalization for HF
- Usual care with active participation in the telemonitoring program "Zorg Bij Jou" (ZBJ)
- Possession of an iPhone 11 or newer and compatible with the study apps
You may not qualify if:
- Lack of digital literacy or inability to use the device
- Not capable to sign consent
- Referral to hospice
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Deventer Ziekenhuiscollaborator
- Medisch Spectrum Twentelead
- Saxion University of Applied Sciencescollaborator
- University of Twentecollaborator
- Ziekenhuisgroep Twentecollaborator
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 1, 2026
First Posted
July 8, 2026
Study Start
July 1, 2026
Primary Completion (Estimated)
December 1, 2027
Study Completion (Estimated)
December 1, 2027
Last Updated
July 8, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will not share
Personal medical data